Home > Insider Trading > Filing (0001225208-20-001876)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
21665	Colgate Palmolive Co	CL	Perfumes, Cosmetics & Other Toilet Preparations (2844)	131815595

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1765088	W John Kooyman	C/O Colgate-Palmolive Company 300 Park Avenue New York NY 10022	Chief Marketing Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-06	10,955	$61.93	17,676	No	4	M	Direct
Common Stock	Acquisiton	2020-02-06	9,720	$64.00	27,396	No	4	M	Direct
Common Stock	Disposition	2020-02-06	21,294	$76.33	6,102	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-06	9,720	$0.00	9,720	$64.00
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-06	10,955	$0.00	10,955	$61.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-09-10	No	4	M	Direct
10,000		2021-09-10	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,576	Indirect	By Issuer's 401(k) Plan Trustee

Footnotes

Exercise of stock options awarded under the issuer's incentive compensation plan.
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $76.01 to $76.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2014 grant date.
Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2015 grant date.